AUG 03, 2020 2:57 PM PDT

New research on fusion proteins that may help young patients with synovial sarcoma

New research is published by scientists at Dana-Farber Cancer Institute have discovered new information that may help patients with synovial sarcoma, a highly aggressive and rare cancer. The research was published recently in Nature Structural and Molecular Biology.

"We have for the first time defined the molecular basis for the cancer-specific targeting properties of the culprit fusion protein, SS18-SSX, found in 100% of cases of synovial sarcoma," said lead investigator and senior author Cigall Kadoch, PhD. "Importantly, this provides a powerful new therapeutic identification strategy for the drug discovery industry" to synthesize drugs capable of impeding interactions between the abnormal fusion protein and nucleosomes.

Sarcoma is triggered by a cellular anomaly when two proteins are joined to form a fusion protein that then causes malignant malfunctions. When the SS18-SSX fusion oncoprotein replaces the normal SS18 subunit in BAF chromatin remodeling complexes, the wrong chromatin sites are activatedSynovial sarcoma affects muscle tissues in the extremities and mostly affects young people.

In this most recent research, Kadoch and her team expanded upon their past work, identifying the complex process of how the SS18-SSX fusion protein and BAF complexes were targeted to the wrong sites. The process involves the erroneous binding of the fusion protein to the acidic patch on nucleosomes, which ultimately causes the activation of cancer-related genes.

The authors write in their publication, “Our results describe a functional interplay between a key nucleosome binding hub and a histone modification that underlies the disease-specific recruitment of a major chromatin remodeling complex.”

The investigators hope their findings will inform the drug development industry to help produce better treatment options for patients. As Kadoch concludes, "these results suggest that inhibition of the interactions between SS18-SSX-bound BAF complexes and H2AK119Ub -marked nucleosomes using small molecules or peptides may prove a viable therapeutic strategy for synovial sarcoma."

Sources: Nature Structural and Molecular Biology, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 10, 2020
Cardiology
Liposomal Delivery Could Help Prevent Doxorubicin Cardiotoxicity
NOV 10, 2020
Liposomal Delivery Could Help Prevent Doxorubicin Cardiotoxicity
One of the greatest failures of modern cancer therapies is the rather substantial off-target toxic effects many radio-, ...
DEC 07, 2020
Cancer
Black women with breast cancer have higher rates of mortality and comorbidities
DEC 07, 2020
Black women with breast cancer have higher rates of mortality and comorbidities
New research published today the American Cancer Society’s peer-reviewed journal, Cancer, looks at the mortality r ...
DEC 27, 2020
Immunology
A Fatty Diet can be Fuel for Tumor Growth!
DEC 27, 2020
A Fatty Diet can be Fuel for Tumor Growth!
Obesity is a significant problem in our societies with increasing the risk for many diseases, including cancer. Can ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
JAN 11, 2021
Cancer
Sentinel Nodes Could Reveal a Tumor's Prognosis
JAN 11, 2021
Sentinel Nodes Could Reveal a Tumor's Prognosis
For many diseases, the ability to quickly and effectively diagnose or prognose a patient is critical. If caught early on ...
JAN 18, 2021
Cancer
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
JAN 18, 2021
An "E-Nose" Could Help Doctors Diagnose Breast Cancer and Its Subtypes
Breast cancer is one of the most well-studied cancers in modern medicine. Diagnostics can already differentiate between ...
Loading Comments...